project id: TCGA-KIRP; case submitter id: TCGA-PJ-A8JU; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; concentration: 0.17; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.8; age at index: 81; days to birth: -29830; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1932; age at diagnosis: 29830; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage I; ajcc clinical t: T1a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 380.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.273972602739726; pack years smoked: 5.0; years smoked: 5.0; is ffpe: false; composition: Not Reported; days to collection: 22; days to sample procurement: 0; initial weight: 310.0; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor nuclei: 95.0;